Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival

PURPOSE: Rising incidence of pancreatic ductal adenocarcinoma (PDAC) bind with insufficient therapy options showcases a great medical challenge. Further biomarkers are required to identify patients, who will benefit from more aggressive therapy. METHODS: 320 patients were included by the PANCALYZE s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Su Ir, Krey, Thaddaeus, Damanakis, Alexander I., Zhao, Yue, Bruns, Christiane J., Schmidt, Thomas, Popp, Felix C., Quaas, Alexander, Knipper, Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374670/
https://www.ncbi.nlm.nih.gov/pubmed/36971797
http://dx.doi.org/10.1007/s00432-023-04702-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374670/
https://www.ncbi.nlm.nih.gov/pubmed/36971797
http://dx.doi.org/10.1007/s00432-023-04702-5

Ejemplares similares